Vantage Point: Healthcare's new promotional target

Share this article:
Jerry Maynor
Jerry Maynor

As US marketers begin 2012, our industry has reached a tipping point where many of the emerging developments from the last five years are finally beginning to resolve. Most prominent among these is the impact from America's decision on national healthcare—a question that the courts and November's election will help answer. While government shapes the payer side, technology will serve an equally important role as trends in social media, electronic health records and telemedicine take better focus over the course of the year.

The recession of the last few years starkly showed that medical practice under the current payer system is not immune to the business cycle.  The recession gave healthcare a short respite from the pressure of a growing, aging patient population—a respite that could be reversed if the US moves toward universal coverage. Greater demand due to the recovery, along with expanded healthcare coverage, is expected to renew the growth of paraprofessionals as the new gatekeepers for most patients.

To marketers, a shift in gatekeepers means the shift to a new promotional target. Some analysts predict that over half of all calls by 2015 will be fielded by NPs, PAs and others. Our industry will then find itself calling on caregivers whose perspective comes more from patient experiences than from academia—armed with effective generics and focused on containing costs. This new target would be bigger in numbers (possibly reversing the drop in sales-force sizes) while representing an expanded patient population that could reinvigorate branded growth. Marketers must respond to this challenge with new strategies tailored to the paraprofessionals' perspectives and needs.

Jerry Maynor is US marketing and business development director, Cegedim Strategic Data
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Vantage Point

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Vantage Point

Vantage Point: Payers—the "experts" in healthcare research

Vantage Point: Payers—the "experts" in healthcare research

Access to payers is about knowledge, about understanding what they do in their jobs

Vantage Point: Determining "fair market value"

Vantage Point: Determining "fair market value"

Should pharma formulate a super matrix to determine the FMV of research incentives?

Vantage Point: Marketing Support for Clinical Trials

Vantage Point: Marketing Support for Clinical Trials

Pharmaceutical companies must provide robust marketing support for their clinical trials